0001062993-26-002233.txt : 20260430 0001062993-26-002233.hdr.sgml : 20260430 20260430151913 ACCESSION NUMBER: 0001062993-26-002233 CONFORMED SUBMISSION TYPE: SCHEDULE 13D/A PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20260430 DATE AS OF CHANGE: 20260430 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: JAPAN SMALLER CAPITALIZATION FUND INC CENTRAL INDEX KEY: 0000859796 ORGANIZATION NAME: EIN: 133553469 STATE OF INCORPORATION: MD FISCAL YEAR END: 0228 FILING VALUES: FORM TYPE: SCHEDULE 13D/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-59337 FILM NUMBER: 26924139 BUSINESS ADDRESS: STREET 1: WORLDWIDE PLAZA STREET 2: 309 WEST 49TH STREET CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 8008330018 MAIL ADDRESS: STREET 1: WORLDWIDE PLAZA STREET 2: 309 WEST 49TH STREET CITY: NEW YORK STATE: NY ZIP: 10019 FORMER COMPANY: FORMER CONFORMED NAME: JAPAN OTC EQUITY FUND INC DATE OF NAME CHANGE: 19920703 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Saba Capital Management, L.P. CENTRAL INDEX KEY: 0001510281 ORGANIZATION NAME: EIN: 800361690 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13D/A BUSINESS ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 BUSINESS PHONE: 212-542-4635 MAIL ADDRESS: STREET 1: 405 LEXINGTON AVENUE STREET 2: 58TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10174 SCHEDULE 13D/A 1 primary_doc.xml X0202 SCHEDULE 13D/A 0001510281 XXXXXXXX LIVE 7 Common Shares, $0.1 par value 04/29/2026 false 0000859796 47109U104 JAPAN SMALLER CAPITALIZATION FUND, INC.
Worldwide Plaza 309 West 49th Street New York NY 10019
Saba Capital Management, L.P. (212) 542-4635 405 Lexington Avenue, 58th Floor Attention: Michael D'Angelo New York NY 10174 0001510281 N Saba Capital Management, L.P. OO N DE 0 1906742 0 1906742 1906742 N 6.73 PN IA The percentages used herein are calculated based upon 28,333,893 shares of common stock outstanding as of 9/26/25, as disclosed in the company's DEF 14A filed 10/14/25. 0001608233 N Boaz R. Weinstein OO N NY 0 1906742 0 1906742 1906742 N 6.73 OO The percentages used herein are calculated based upon 28,333,893 shares of common stock outstanding as of 9/26/25, as disclosed in the company's DEF 14A filed 10/14/25. Y Saba Capital Management GP, LLC OO N DE 0 1906742 0 1906742 1906742 N 6.73 OO The percentages used herein are calculated based upon 28,333,893 shares of common stock outstanding as of 9/26/25, as disclosed in the company's DEF 14A filed 10/14/25. Common Shares, $0.1 par value JAPAN SMALLER CAPITALIZATION FUND, INC. Worldwide Plaza 309 West 49th Street New York NY 10019 This Amendment No. 7 amends Items 3, 5, and 7. This Schedule 13D/A is being jointly filed by: (i) Saba Capital Management, L.P., a Delaware limited partnership ("Saba Capital"); (ii) Saba Capital Management GP, LLC, a Delaware limited liability company ("Saba GP"); and (iii) Mr. Boaz R. Weinstein ("Mr. Weinstein"), (together, the "Reporting Persons"). Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party. The filing of this statement should not be construed as an admission that any Reporting Person is, for the purposes of Sections 13 of the Securities Exchange Act of 1934, the beneficial owner of the Common Shares reported herein. The address of the business office of each of the Reporting Persons is 405 Lexington Avenue, 58th Floor, New York, New York 10174. The principal business of: (i) Saba Capital is to serve as investment manager to private and public investment funds and/or accounts, (ii) Saba GP is to serve as general partner of the Saba Capital and other affiliated entities, and (iii) Mr. Weinstein, an individual, is managing member of the general partner of Saba Capital and other affiliated entities. The Reporting Persons have not, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors). The Reporting Persons have not, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and, as a result of such proceeding, was, or is subject to, a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws. Saba Capital is organized as a limited partnership under the laws of the State of Delaware. Saba GP is organized as a limited liability company under the laws of the State of Delaware. Mr. Weinstein is a citizen of the United States. Funds for the purchase of the Common Shares were derived from the subscription proceeds from investors and the capital appreciation thereon and margin account borrowings made in the ordinary course of business. In such instances, the positions held in the margin accounts are pledged as collateral security for the repayment of debit balances in the account, which may exist from time to time. Since other securities are held in the margin accounts, it is not possible to determine the amounts, if any, of margin used to purchase the Common Shares reported herein. A total of approximately $15,579,583 was paid to acquire the Common Shares reported herein. Not Applicable. See the Reporting Persons section of this Schedule 13D/A for the aggregate number of Common Shares and percentages of the Common Shares beneficially owned by each of the Reporting Persons. The percentages used herein are calculated based upon 28,333,893 shares of common stock outstanding as of 9/26/25, as disclosed in the company's DEF 14A filed 10/14/25. See the Reporting Persons section of this Schedule 13D/A for the number of Common Shares as to which each Reporting Person has the sole or shared power to vote or direct the vote and sole or shared power to dispose or to direct the disposition. The transactions in the Common Shares effected by the Reporting Persons within the past sixty days prior to 4/29/26, the date of the event which required filing of this Schedule 13D/A, which were all in the open market, are set forth in Schedule A, and are incorporated herein by reference. The funds and accounts advised by Saba Capital have the right to receive the dividends and proceeds of sales from the Common Shares. N/A Not Applicable. Exhibit 9 - Schedule A Saba Capital Management, L.P. /s/ Michael D'Angelo General Counsel 04/30/2026 Boaz R. Weinstein /s/ Michael D'Angelo Authorized Signatory 04/30/2026 Saba Capital Management GP, LLC /s/ Michael D'Angelo Attorney-in-fact* 04/30/2026 Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 EX-9 2 exhibit9.htm EXHIBIT 9 Saba Capital Management, L.P.: Exhibit 9 - Filed by newsfilecorp.com

EXHIBIT 9

Schedule A

This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital within the past sixty days prior to 4/29/26, the date of the event which required filing of this Schedule 13D/A.  All transactions were effectuated in the open market through a broker. 

Trade Date Buy/Sell Shares Price
3/4/2026 Sell 28,089 11.75
3/18/2026 Buy 41,786 10.94
3/19/2026 Buy 27,328 10.55
3/20/2026 Buy 53,300 10.49
3/26/2026 Buy 18,376 10.64
3/27/2026 Buy 29,967 10.59
4/9/2026 Buy 17,250 10.95
4/10/2026 Buy 60,942 11.00
4/13/2026 Buy 47,980 10.98
4/14/2026 Buy 8,348 11.10
4/15/2026 Buy 33,520 11.03
4/16/2026 Buy 31,552 11.09
4/21/2026 Buy 6,803 11.06
4/28/2026 Buy 46,261 11.01
4/29/2026 Buy 52,280 10.98